Revive Therapeutics Announces Extension of Proposed Private Placement
TORONTO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or…
Helios Alliance Announces National Opioid Conference Featuring Former White House Drug Policy Director Dr. Rahul Gupta
September 05, 2025 16:45 ET | Source: Helios Alliance Mobile, Alabama ,…
Altai Provides Update on Quebec Litigation
September 05, 2025 18:39 ET | Source: Altai Resources Inc. TORONTO, Sept.…
Enovix Announces Completion of Warrant Dividend Program
September 05, 2025 18:08 ET | Source: Enovix Corporation Warrants Expired and…
Rackspace Technology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 05, 2025 18:00 ET | Source: Rackspace US, Inc. SAN ANTONIO,…
Adagenes ADG126 to be Highlighted in Two Presentations at the 2025 Chinese Society of Clinical Oncology (CSCO) Meeting in Jinan, China
September 05, 2025 09:55 ET | Source: Adagene Inc. SAN DIEGO and…
MAIA Biotechnology Abstract Selected for Poster Presentation at 2025 IASLC World Conference on Lung Cancer
Poster details durability and efficacy of ateganosine (THIO) treatment in non-small cell…
Mineralys Therapeutics Presents Subgroup Analyses of Phase 3 Launch-HTN Trial Demonstrating Efficacy and Safety of Lorundrostat in Hypertension Participants with High Unmet Medical Need
~Pivotal Launch-HTN trial of novel aldosterone synthase inhibitor lorundrostat enrolled a diverse…
iManage Reports Strong ANZ Growth as Firms Embrace Cloud and AI
Company highlights customer momentum and innovations at ALPMA Summit + ALTACON 2025…
XRP News: Sparkvia AI Public Sale is Open Why SPARK Token Is The Must-Have Utility Token on XRP
VALLETTA, Malta, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Tokens with day-one utility…
